CLINICAL_TRIALS
trial_result
· 2015-09-04
Clinical Trial Update: Toviaz Post Marketing Surveillance Study
Summary
Post-marketing surveillance study of fesoterodine (Toviaz) for overactive bladder completed; results were posted on 2015-09-04.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Overactive Bladder | Status: COMPLETED | Results posted: 2015-09-04